Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xintela AB | 315,000 | net | 05 Dec 2025 | tx 2+315,000 |
| Idogen AB | 114,285 | net | 06 Dec 2018 | tx 1+114,285 |
| RhoVac AB | 38,892 | net | 04 Jun 2018 | tx 2+38,892 |
| Scandinavian Chemotech AB | 8,427 | net | 02 Nov 2022 | tx 1+8,427 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Dec 2025 | PURCHASE | Xintela AB | 260,000 | 0.26 SEK | first after silence |
| 28 Jun 2023 | GRANT_AWARD | Xintela AB | 55,000 | 0.90 SEK | |
| 02 Nov 2022 | PURCHASE | Scandinavian Chemotech AB | 8,427 | 6.25 SEK | first after silence |
| 06 Dec 2018 | PURCHASE | Idogen AB | 114,285 | 1.75 SEK | |
| 30 May 2018 | GRANT_AWARD | RhoVac AB | 33,336 | 0.00 SEK | |
| 04 Jun 2018 | PURCHASE | RhoVac AB | 5,556 | 18.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 05 Dec 2025.